Study of LEE011 With Fulvestrant and BYL719 or BKM120 in Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: LEE011|DRUG: BYL719|DRUG: fulvestrant|DRUG: BKM120
Sponsor: Novartis Pharmaceuticals